Activation of caspases and apoptosis in response to low-voltage electric pulses

Oncology Reports

Volumn 23, Issue 5, 2010, Pages 1425-1433

  Matsuki, Noriaki ^a   Takeda, Motohiro ^b   Ishikawa, Takuji ^a   Kinjo, Aki ^c   Hayasaka, Tomoaki ^b   Imai, Yohsuke ^b   Yamaguchi, Takami ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Apoptosis; Caspase 3; Low voltage electric pulse; Membrane permeability; Z VAD FMK

Indexed keywords

CALCIUM ION; CASPASE 3; CASPASE 8; CASPASE 9; CASPASE INHIBITOR; PROPIDIUM IODIDE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL DEATH; CELL GROWTH; CELL MEMBRANE PERMEABILITY; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; GROWTH INHIBITION; MEMBRANE TRANSPORT; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PULSED ELECTRIC FIELD;

AMINO ACID CHLOROMETHYL KETONES; ANIMALS; APOPTOSIS; CASPASE 3; CASPASE 8; CASPASE 9; CASPASES; CELL LINE; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; CELL SURVIVAL; CYSTEINE PROTEINASE INHIBITORS; ELECTRIC STIMULATION; ENZYME ACTIVATION; MELANOMA, EXPERIMENTAL; MEMBRANE POTENTIALS; MICE; TIME FACTORS;

EID: 77950853704     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000780     Document Type: Article

References (39)

1. Weaver JC: Electroporation of cells and tissues. IEEE T Plasma Sci 28: 24-33, 2000.
2. Rubinsky B: Irreversible electroporationin medicine. Technol Cancer Res 6: 255-259, 2007.
3. Sersa G, Miklavcic D, Cemazar M, Rudolf Z, Pucihar G and Snoj M: Electrochemotherapy in treatment. EJSO 34: 232-240, 2007.
4. Teissie J, Golzio M and Rols MP: Mechanism of cell membrane electropermeabilization: a minireview of our present (lack of ?) knowledge. BBA 1724: 270-280, 2005.
5. Hoffmann F, Ohnimus H, Scheller C, Strupp W, Zimmermann U and Jassoy C: Electric field pulses can induce apoptosis. J Membr Biol 169: 103-109, 1999.
6. Hilpert F, Heisert A, Wieckhorst W, Arnold N, Kabelitz D, Jonat W and Pfisterer J: The impact of electricalcharge on the viability and physiology of dendric cells. Scand J Immunol 62: 399-406, 2005.
7. Beebe SJ, Fox PM, Rec LJ, Willis LK and Schoenbach KH: Nanosecond, high-intensity pulsed electric fields induce apoptosis in human cells. FASEB J 17: 1493-1495, 2003.
8. Galluzzi L, Maiuri MC, Vitale I, Zischka H, Castedo M, Zitvogel L and Kroemer G: Cell death modalities: classification and pathophysiological implications. Cell Death Differ 14: 1237-1243, 2007.
9. Elmore S: Apoptosis: a review of programmed cell death. Toxicol Pathol 35: 495-516, 2007.
10. Russo A, Terrasi M, Agnese V, Santini D and Bazan V: Apoptosis: a relevant tool for anticancer therapy. Ann Oncol 17 (Suppl 7): vii115-vii123, 2006.
11. Tang LL, Sunn CX, Liu H, Mi Y, Yao CG and Li CX: Steep pulsed electric fields modulate cell apoptosis through the change of intracellular calcium concentration. Colloids Surf B Biointerfaces 57: 209-214, 2007.
12. Matsuki N, Ishikawa T, Imai Y and Yamaguchi T: Low voltage pulses can induce apoptosis. Cancer Lett 269: 93-100, 2008.
13. Rosenberg Y and Korenstein R: Incorporation of macromolecules into cells and vesicles by low electric fields: induction of endocytotic- like processes. Bioelectrochem Bioenergetics 42: 275-281, 1997.
14. Antov Y, Barbul A and Korenstein R: Electroendocytosis: stimulation of adsorptive and fluid-phase uptake by pulsed low electric fields. Exp Cell Res 297: 348-362, 2004.
15. Entin I, Plotnikov A, Korenstein R and Keisari Y: Tumor growth retardation, cure, and induction of antitumor immunity in B16 melanoma-bearing mice by low electric field-enhanced chemotherapy. Clin Cancer Res 3190: 3190-3197, 2003.
16. Hock BD, Roberts G, McKenzie JL, Gokhale P, Salm N, McLellan AD, Patton NW and Roake JA: Exposure to the electrofusion process can increase the immunogenicity of human cells. Cancer Immunol Immunother 54: 880-890, 2005.
17. Jiang M, Wang CY, Huang S, Yang T and Dong Z: Cisplatininduced apoptosis in p53-deficient renal cells via the intrinsic mitochondrial pathway. Am J Physiol Renal Physiol 296: 983-993, 2009.
18. Konstantakou EG, Voutsinas GE, Karkoulis PK, Aravantinos G, Margaritis LH and Stravopodis DJ: Human bladder cancer cells undergo cisplatin-induced apoptosis that is associated with p53- dependent and p53-independent responses. Int J Oncol 35: 401-416, 2009.
19. Pucihar G, Kotnik T, Teissie J and Miklavcic D: Electropermeabilization of dense cell suspensions. Eur Biophys J 36: 173-185, 2007.
20. Rols MP and Teissie J: Electropermeabilization of mammalian 0cells to macromolecules: control by pulse duration. Biophys J 75: 1415-1423, 1998.
21. Zaharoff DA, Henshaw W, Mossop B and Yuan F: Mechanistic analysis of electroporation-induced cellular uptake of macromolecules. Exp Biol Med 233: 94-105, 2008.
22. Hojman P, Gissel H, Andre FM, Cournil-Henrionnet C, Eriksen J, Gehl J and Mir LM: Physiological effects of high- and lowvoltage pulse combinations forngene electrotransfer in muscle. Hum Gene Ther 19: 1249-1260, 2008.
23. 2+ increase and apoptois induced by Pinacidil in HepG2 human hepatoblastoma cells. BBRC 281: 511-519, 2001.
24. Vernier PT, Sun Y, Chen MT, Gundersen MA and Craviso GL: Nanosecond electric pulse-induced calcium entry into chromaffin cells. Bioelectrochem 73: 1-4, 2008.
25. Kumar S: Caspase function in programmed cell death. Cell Death Differ 14: 32-43, 2007.
26. Li J and Yuan J: Caspases in apoptosis and beyond. Oncogene 27: 6194-6202, 2008.
27. Taylor RC, Cullen SP and Martin SJ: Apoptosis: controlled demolition at the cellular level. Mol Cell Biol 9: 231-241, 2008.
28. Wang GY, Lv QH, Dong Q, Xu RZ and Dong QH: Berbamine induces Fas-mediated apoptosis in human hepatocellular carcinoma HepG2 cells and inhibits its tumor growth in nude mouse. J Asian Nat Prod Res 11: 219-228, 2009.
29. Hermanson D, Addo SN, Bajer AA, Marchant JS, Das SGK, Srinivasan B, Al-Mousa F, Michelangeli F, Thomas DD, LeBien TW and Xing C: Dual mechanism of sHA14-1 in inducing cell death through endoplasmic reticulum and mitochondria. Mol Pharmacol 76: 667-678, 2009.
30. Misaghi S, Korbel GA, Kessler B, Spooner E and Ploegh HL: z-VAD-fmk inhibits peptide: N-glycanase and may result in ER stress. Cell Death Differ 13: 163-165, 2006.
31. Hussain SG and Ramaiah KVA: Endoplasmic reticulum: stress, signaling and apoptosis. Curr Sci 93: 1684-1696, 2007.
32. Heath-Engel HM, Chang NC and Shore GC: The endoplasmic reticulum in apoptosis and autophagy: role of the Bcl-2 protein family. Oncogene 27: 6419-6433, 2008.
33. Yee SB, Baek SJ, Park HT, Jeong SH, Jeong JH, Kim TH, Kim JM, Jeong BK, Park BS, Kwon TK, Yoon II and Yoo YH: z-VAD-fmk, unlike BocD-fmk, does not inhibit caspase-6 acting on 14-3-3/Bad pathway in apoptosis of p815 mastcytoma cells. Exp Mol Med 38: 634-642, 2006.
34. Huang J, Wu L, Tashiro S, Onodera S and Ikejima T: The augmentation of TNF-induced cell death in murine L929 fibrosarcoma by the pan-caspase inhibitor z-VAD-fmk through pre-mitochondial and MAPK-dependent pathway. Acta Med Okayama 59: 253-260, 2005.
35. Miura T, Chiba M, Kasai K, Nozaka H, Nakamura T, Shoji T, Kanda T, Ohtake Y and Sato T: Apple procyanidins induce tumor cell apoptosis through mitochondrial pathway activation of caspase-3. Carcinogenesis 29: 585-593, 2008.
36. Wu X, Simone J, Hewgill D, Siegel R, Lipsky P and He L: Measurement of two caspase activities simultaneously in living cells by a novel FRET fluorescent indicator probe. Cytometry A 69A: 477-486, 2006.
37. Liang Y, Yan C and Schor NF: Apoptosis in the absence of caspase 3. Oncogene 20: 6570-6578, 2001.
38. Herr I and Debatin KM: Cellular stress response and apoptosis in cancer therapy. Blood 98: 2603-2614, 2001.
39. Okutsu S, Hatakeyama H, Kanzaki M, Tsubokawa H and Nagatomi R: Electric pulse stimulation induces NMDA glutamate receptor mRNA in NIH3T3 mouse fibroblast. Tohoku J Exp Med 216: 181-187, 2008.